BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34308507)

  • 21. Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.
    Mazeh H; Deutch T; Karas A; Bogardus KA; Mizrahi I; Gur-Wahnon D; Ben-Dov IZ
    Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):858-863. PubMed ID: 30049841
    [No Abstract]   [Full Text] [Related]  

  • 22. Should Core Needle Biopsy be Used in the Evaluation of Thyroid Nodules?
    Guler B; Kiran T; Arici DS; Aysan E; Sonmez FC
    Endocr Pathol; 2016 Dec; 27(4):352-358. PubMed ID: 27306998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound-Pathology Discordant Nodules on Core-Needle Biopsy: Malignancy Risk and Management Strategy.
    Chung SR; Baek JH; Park HS; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
    Thyroid; 2017 May; 27(5):707-713. PubMed ID: 28326900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid nodule molecular profiling: The clinical utility of Afirma Xpression Atlas for nodules with Afirma Genomic Sequencing Classifier-suspicious results.
    Babazadeh NT; Sinclair TJ; Krishnamurthy V; Jin J; Heiden KB; Shin J; Berber E; Siperstein A
    Surgery; 2022 Jan; 171(1):155-159. PubMed ID: 34924179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UTILITY OF ULTRASOUND VERSUS GENE EXPRESSION CLASSIFIER IN THYROID NODULES WITH ATYPIA OF UNDETERMINED SIGNIFICANCE.
    Villabona CV; Mohan V; Arce KM; Diacovo J; Aggarwal A; Betancourt J; Amer H; Jose T; DeSantis P; Cabral J
    Endocr Pract; 2016 Oct; 22(10):1199-1203. PubMed ID: 27409819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
    Teshima M; Tokita K; Ryo E; Matsumoto F; Kondo M; Ikegami Y; Shinomiya H; Otsuki N; Hiraoka N; Nibu KI; Yoshimoto S; Mori T
    BMC Cancer; 2019 Mar; 19(1):245. PubMed ID: 30885146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Consecutive Results from Fine Needle Aspiration and Core Needle Biopsy in Thyroid Nodules.
    Ahn SH; Park SY; Choi SI
    Endocr Pathol; 2017 Dec; 28(4):332-338. PubMed ID: 28748505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound Risk Assessment Combined with Molecular Markers of Galectin-3, c-MET, HBME-1 and CK19 for Diagnosis of Malignant and Benign Thyroid Nodules.
    Han RL; Wang J; Zhang FJ; Zhao N; Gao BL
    Pathol Oncol Res; 2019 Jul; 25(3):1075-1081. PubMed ID: 30361909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenge in the Pathological Diagnosis of the Follicular- Patterned Thyroid Lesions.
    Elsers DA; Hussein MRA; Osman MH; Mohamed GA; Hosny G
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3365-3376. PubMed ID: 34711014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of thyroid fine needle aspiration biopsy results before and after implementation of Bethesda classification.
    Ozdemir D; Bestepe N; Faki S; Kilicarslan A; Parlak O; Ersoy R; Cakir B
    Cytopathology; 2017 Oct; 28(5):400-406. PubMed ID: 28727204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fine-needle aspiration.
    Trimboli P; Nasrollah N; Guidobaldi L; Taccogna S; Cicciarella Modica DD; Amendola S; Romanelli F; Lenzi A; Nigri G; Centanni M; Giovanella L; Valabrega S; Crescenzi A
    World J Surg Oncol; 2014 Mar; 12():61. PubMed ID: 24661377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase 4 and crystallin α-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology.
    Davidov T; Nagar M; Kierson M; Chekmareva M; Chen C; Lu SE; Lin Y; Chernyavsky V; Potdevin L; Arumugam D; Barnard N; Trooskin S
    J Surg Res; 2014 Aug; 190(2):565-74. PubMed ID: 24880201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galectin-3 cytotest in thyroid follicular neoplasia: a prospective, monoinstitutional study.
    Pennelli G; Mian C; Pelizzo MR; Naccamulli D; Piotto A; Girelli ME; Mescoli C; Rugge M
    Acta Cytol; 2009; 53(5):533-9. PubMed ID: 19798881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Immunohistochemistry in Fine Needle Aspiration and Core Needle Biopsy of Thyroid Nodules.
    Song S; Kim H; Ahn SH
    Clin Exp Otorhinolaryngol; 2019 May; 12(2):224-230. PubMed ID: 30531651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Core Needle Biopsy in the Diagnosis of Thyroid Nodules.
    Aysan E; Guler B; Kiran T; Idiz UO
    Am Surg; 2023 Dec; 89(12):5170-5174. PubMed ID: 36416390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
    Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
    Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Core needle biopsy of thyroid nodules: outcomes and safety from a large single-center single-operator study.
    Choe J; Baek JH; Park HS; Choi YJ; Lee JH
    Acta Radiol; 2018 Aug; 59(8):924-931. PubMed ID: 29137498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
    Jeon MJ; Song DE; Jung CK; Kim WG; Kwon H; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
    PLoS One; 2016; 11(12):e0167756. PubMed ID: 27936121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application.
    Ralhan R; Veyhl J; Chaker S; Assi J; Alyass A; Jeganathan A; Somasundaram RT; MacMillan C; Freeman J; Vescan AD; Witterick IJ; Walfish PG
    Thyroid; 2015 Nov; 25(11):1224-34. PubMed ID: 26131603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.